Nonoperating Income (Expense) in USD of BioCorRx Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioCorRx Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from 2014 to Q3 2025.
  • BioCorRx Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $1.14M, a 675% increase year-over-year.
  • BioCorRx Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $1.16M.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2024 was -$89.6K, a 618% decline from 2023.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2023 was $17.3K, a 94.6% decline from 2022.
  • BioCorRx Inc. annual Nonoperating Income (Expense) for 2022 was $321K, a 7.24% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BioCorRx Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.16M $1.14M +$990K +675% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $167K $36.6K -$98.7K -72.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $265K $86.2K +$355K Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$89.6K -$103K +$43.4K +29.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$133K $147K +$52.2K +55.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$185K $135K +$112K +480% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$297K -$269K -$315K -688% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $17.3K -$146K -$169K -741% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $186K $94.5K +$16.4K +21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $170K $23.4K -$17.2K -42.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $187K $45.7K -$134K -74.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $321K $22.8K -$109K -82.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $430K $78.1K -$193K -71.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $623K $40.5K +$139K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $484K $180K +$185K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $299K $131K -$731K -84.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 $1.03M $271K -$996K -78.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.03M -$98.5K -$1.51M -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $3.54M -$4.85K -$444K -101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $3.99M $863K +$470K +120% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $3.52M $1.27M +$1.42M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.1M $1.42M +$1.86M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $243K $439K +$730K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$487K $392K +$922K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$1.41M -$148K +$337K +69.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.75M -$441K +$39.1K +8.14% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$1.79M -$290K +$173K +37.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$1.96M -$530K +$13.6K +2.51% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$1.97M -$485K -$46.9K -10.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.93M -$480K -$12.6M -104% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $10.6M -$463K +$37.5M +98.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$26.8M -$544K +$231K +29.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$27M -$438K +$1.65M +79% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$28.7M $12.1M +$12.8M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$41.5M -$37.9M -$37.7M -19455% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-18
Q4 2016 -$3.72M -$775K -$1.48M -210% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-05
Q3 2016 -$2.25M -$2.09M -$1.9M -994% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$345K -$661K -$798K -583% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $453K -$194K +$1.58K +0.81% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $452K $702K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-13
Q3 2015 -$191K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 $137K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-17
Q1 2015 -$196K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-23

BioCorRx Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$89.6K -$107K -618% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $17.3K -$304K -94.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $321K +$21.7K +7.24% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $299K -$3.69M -92.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $3.99M +$4.47M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$487K +$1.47M +75.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$1.96M +$24.9M +92.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$26.8M -$23.1M -620% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 -$3.72M -$4.17M -924% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-05
2015 $452K +$527K Jan 1, 2015 Dec 31, 2015 10-K 2017-04-13
2014 -$75.2K Jan 1, 2014 Dec 31, 2014 10-K 2016-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.